Scalable synthesis of imidazole derivatives

Details Scalable synthesis of imidazole derivatives Scalable synthesis of imidazole derivatives

2009-02-02

2010-10-05

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S322000

Reexamination Certificate

active

07807837

ABSTRACT:
Imidazole derivatives, compositions containing them, methods of preparing them, including regioselective scale-up synthetic methods, and methods of using them.

REFERENCES:
patent: 5217986 (1993-06-01), Pomponi et al.
patent: 5352707 (1994-10-01), Pompni et al.
patent: 5869479 (1999-02-01), Kreutner et al.
patent: 6207678 (2001-03-01), Monaghan et al.
patent: 6380396 (2002-04-01), Monaghan et al.
patent: 7265135 (2007-09-01), Bogenstaetter et al.
patent: 2002/0198237 (2002-12-01), Bogenstaetter et al.
patent: 0978512 (2000-02-01), None
patent: 63-239273 (1988-10-01), None
patent: WO 99/42458 (1999-08-01), None
patent: WO 02/076925 (2002-10-01), None
patent: WO 02/079168 (2002-10-01), None
O'Connell et al., Synthesis (1988), (10), 767-71.
Arrang, J.M. et al.: Auto-inhibition of Brain Histamine Release Mediated by a Novel Class (H3) of Histamine Receptor.Nature(1983) 302: 832-837.
Ash, A.S.F et al.: Receptors Mediating Some Actions of Histamine.Br. J. Pharmac. Chemother. (1966) 27: 427-439.
Barnes, J.C. et al.: The Selective Histamine H3 Receptor Antagonist Thioperamide Improves Cognition and Enhances Hippocampal Acetylcholine Release in Vivo.Soc. Neurosci. Abstr.(1993) 19: 1813.
Black, J.W. et al.: Definition and Antagonism of Histamine H2-Receptors.Nature(1972) 236: 385-390.
Boga, C. et al.: A New Synthesis of Chloroheterocycles via Metal-Halogen Exchange between Trichloroacetyl Derivatives and Heteroaromatic Lithium and Grignard Reagents.J. Organomet. Chem. (1999) 588: 155-159.
Boga, C. et al.: Tetrahalogenomethanes: Simple Reagents for the Synthesis of Monochalogenated and Mixed Dihalogenated Aromatic Heterocycles via Metal-Halogen Exchange from Lithium Compounds.J. Organomet. Chem. (2000) 601: 233-236.
Ding, Y.-S et al.: Synthesis of High Specific Activity (+) and (−)-6[18F]-Fluoronorepinephrine via the Nucleophilic Aromatic Substitution Reaction.J. Med. Chem. (1991) 34: 767-771.
Eriksen, B.L. et al.: Synthesis of 4-and 5-Substituted 1-Hydroxyimidazoles through Directed Lithiation and Metal-Halogen Exchange.J. Org. Chem. (2001) 66:8344-8348.
Ganellin, C.R. et al.: Synthesis of Potent Non-Imidazole Histamine H3-Receptor Antagonists.Arch. Pharm. Pharm. Med. Chem. (Weinheim, Ger.) (1998) 331: 395-404.
Garbarg, M. et al.: S-[2-(4-Imidazolyl)ethyl]isothiourea, a Highly Specific and Potent Histamine H3Receptor Agonist.J. Pharmacol. Exp. Ther. (1992) 263(1):304-310.
Gewald, K. et al.: 4-Amino-imidazole durch Thorpe-Cyclisierung.Monatsh. Chem. (1976) 107: 1413-1421. (Note: This article is not in English. Look to the tables and drawings for relevance.).
Gilman, H. et al.: Some Factors Affecting Halogen-Metal Interconversions.J. Am. Chem. Soc. (1940) 62: 1843-1846.
Gilatech, Inc. Press Release: Nov. 5, 1998.
Grimmett, M.R.: Imidazoles. InComprehensive Heterocyclic Chemistry II, A Review of the Literature 1982-1995; Katritsky, A.R. et al., Eds.; Elsevier: Tarrytown, NY, (1996) 3: 136-139.
Ichinose, M. et al.: Histamine H3-Receptors Modulate Nonadrenergic Noncholinergic Neural Bronchoconstriction in Guinea-Pig In Vivo.Eur. J. Pharmacol. (1989) 174(1): 49-55.
Imamura, M. et al.: Unmasking of Activated Histamine H3-Receptorsin Myocardial Ischemia: Their Role as Regulators of Exocytotic Norepinephrine Release.J. Pharmacol. Exp. Ther. (1994) 271(3): 1259-1266.
Imbach, J.L. et al.: Recherches dans la Serie des Azoles. Synthese de Chloroimidazoles Non N-Substitues.J. Heterocycl. Chem. (1967) 4: 451-452. (Note: This article is not in English. Look to the tables for relevance.).
Jarosinski, M.A. et al.: Preparation of Noncondensed 2-Substituted 1-Methylimidazoles via Ipso Substitution Reaction on 2-Sulfinyl or 2-Sulfonyl Derivatives of 4,5-Disubstituted 1-Methylimidazoles.J. Org. Chem. (1991) 56: 4058-4062.
Jones, R.G.: Studies on Imidazoles. II. The Synthesis of 5-Imidazolecarboxylates from Glycine and Substituted Glycine Esters.J. Am. Chem. Soc. (1949) 71: 644-647.
Korte, A. et al.: Characterization and Tissue Distribution of H3Histamine Receptors in Guinea Pigs by N alpha-Methylhistamine.Biochem. Biophys. Res. Commun. (1990) 168(3): 979-986.
Krause et al.: “Medicinal Chemistry of Histamine H3Receptor Agonists”;The Histamine H3Receptor—A Target for New Drugs; Leurs, R. and Timmerman, H., (Eds.), Elsevier, (1998): 175-196.
Leurs, R. et al.: The Medicinal Chemistry and Therapeutic Potentials of Ligands of the Histamine H3Receptor;Prog. Drug. Res. (1995) 45: 107-165.
Lin, J.-S. et al.: Involvement of Histaminergic Neurons in Arousal Mechanisms Demonstrated with H3-Receptor Ligands in the Cat.Brain Res. (1990) 523: 325-330.
Linney, I.D. et al.: Design, Synthesis, and Structure-Activity Relationships of Novel Non-Imidazole Histamine H3Receptor Antagonists.J. Med. Chem. (2000) 43(12): 2362-2370.
Lovenberg, T.W. et al.: Cloning and Functional Expression of the Human Histamine H3Receptor.Mol. Pharmacol. (1999) 55(6): 1101-1107.
Lovenberg, T.W. et al.: Cloning of Rat Histamine H3Receptor Reveals Distinct Species Pharmacological Profiles.J. Pharmacol. Exp. Ther. (2000) 293(3): 771-778.
Machidori, H. et al.: Zucker Obese Rats: Defect in Brain Histamine Control of Feeding;Brain Res. (1992) 590: 180-186.
Mani, N.S. et al.: A Scalable Synthesis of a Histamine H3Receptor Antagonist.J. Org. Chem. (2004) 69: 8115-8117.
McLeod, R.L. et al.: Antimigraine and Sedative Activity of SCH 50971: A Novel Orally-Active Histamine H3Receptor Agonist.Soc. Neurosci. Abstr. (1996) 22: 2010.
Monti, J.M. et al.: Effects of Selective Activation or Blockade of the Histamine H3Receptor on Sleep and Wakefulness.Eur. J. Pharmacol. (1991) 205(3): 283-287.
Morisset, S. et al.: High Constitutive Activity of Native H3Receptors Regulates Histamine Neurons in Brain.Nature(2000) 408: 860-864.
Oda, T. et al.: Molecular Cloning and Characterization of a Novel Type of Histamine Receptor Preferentially Expressed in Leukocytes.J. Biol. Chem. (2000) 275(47): 36781-36786.
Other News to Note.Bioworld Today(1999) 10(40): 3.
Panula, P. et al.: Significant Changes in the Human Brain Histaminergic System in Alzheimer's Disease. Soc. Neurosci. Abstr. (1995) 21: 1977.
Phillips, J.G. et al.: Medicinal Chemistry of Histamine H3Receptor Antagonists. InThe Histamine H3Receptor—A Target for New Drugs. Leurs, R.; Timmerman, H., Eds.; Elsevier: (1998):197-222.
Piotrowski, D.W.: A Concise Route to Novel 1-Aryl and 1-Pyridyl-2-Azabicyclo[2.1.1]hexanes.Synlett(1999) 7: 1091-1093.
Schlicker, E. et al.: The Moderate Affinity of Clozapine at H3Receptors Is Not Shared by Its Two Major Metabolites and by Structurally Related and Unrelated Atypical Neuroleptics.Naunyn-Schmiedeberg's Arch. Pharmacol. (1996) 353: 290-294.
Shrivastava, S.K. et al.: Dextrans—Potential Polymeric Drug Carriers for Flurbiprofen.Pharmazie(2003) 58(6): 389-391.
Stark, H. et al.: Developments of Histamine H3-Receptor Antagonists.Drugs Future(1996) 21(5): 507-520.
Suzuki, M. et al.: Synthesis of 5-Carbon-Substituted 1-β-D- Ribofuranosylimidazole-4-carboxamides via Lithiation of a Primary Carboxamide.Chem. Pharm. Bull. (1987) 35(10): 4056-4063.
Tanaka, H. et al.: A Lithiation Route to C-5 Substitution of an Imidazole Nucleoside and its Application to the Synthesis of 3-Deazaguanosine.Tetrahedron(1986) 42: 1971-1980.
Taylor, S.D. et al.; Recent Advances in Electrophilic Fluorination.Tetrahedron(1999) 55: 12431-12477.
Terasawa, K. et al.: Cytoxic Activity of 5-Benzoylimidazole and Related Compounds against Human Oral Tumor Cell Lines.Anticancer Res. (2000) 21: 1081-1086.
Tozer, M.J. et al.: Histamine H3Receptor Antagonists.Exp. Opin. Ther. Patents(2000) 10(7):1045-1055.
Walczynski, K. et al.: Non-Imidazole Histamine H3Ligands. Part I. Synthesis of 2-(1-Piperaziny1)- and 2-(Hexahydro-1H-1,4-diazepin-1-yl)benzothiazole Derivatives as H3-Antagonists with H1 Blocking Activities.Farmaco(1999) 54: 684-694.
Walczynski, K. et al.: Non-Imidazole Histamine H3Ligands, Part 2: New 2- Substituted Benzothiazoles as Histamine H3Antagonists.Arch. Pharm. Pharm. Med. Chem. (Weinheim, Ger.) (1999) 332: 389-398.
West, R.E. et al.: Identification of Two H3-Histamine Rec

Affiliated with

Also associated with

Rating

Scalable synthesis of imidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Scalable synthesis of imidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Scalable synthesis of imidazole derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4220207